Diagnostic • Prognostic • Predictive
The FISH (Fluorescence in Situ Hybridization) service offered by RosettaGX is best-in-class, with a highly competitive success rate in obtaining informative results in 98% of cases, and a turnaround time of 3 to 4 days.
We utilize FISH technology for the early detection of genomic changes, which may detect cancer, measure the potential aggressiveness of the disease, and identify if patients are likely to respond to specific targeted therapies.
Our FISH platform offers a unique advantage through our tech-only option. We’ll provide the technical component (TC), and Pathologists can provide the professional component (PC). This allows Pathologists to own the complete genomic analysis of each patient, enabling them to deliver expert case results to Oncologists and Urologists through reports that are customizable to the local Pathology brand.
98% of cases yield informative results
Rapid turnaround time of 3-4 days
Learn more about the RosettaGX specialty tests that utilize FISH technology: